
AIkido Pharma AIKI
Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025
AIkido Pharma DPO 2011-2026 | AIKI
DPO Jährlich AIkido Pharma
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | 32.8 K | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 32.8 K | 32.8 K | 32.8 K |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
887 | $ 2.69 | 0.19 % | $ 208 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 27.72 | 1.43 % | $ 1.34 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 11.49 | -2.21 % | $ 743 M | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Axon Enterprise
AXON
|
29.9 | $ 611.74 | -1.48 % | $ 46.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.71 | -4.24 % | $ 17 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
AstraZeneca PLC
AZN
|
265 | $ 94.15 | -1.06 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Biogen
BIIB
|
65.4 | $ 185.27 | -0.88 % | $ 27 B | ||
|
Abeona Therapeutics
ABEO
|
2.52 K | $ 5.1 | -2.39 % | $ 109 M | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
ADiTx Therapeutics
ADTX
|
5.15 K | $ 0.84 | -0.24 % | $ 11.1 K | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M |